248 related articles for article (PubMed ID: 31635446)
1.
Jung DH; Kim GY; Kim IY; Seo DH; Nam YD; Kang H; Song Y; Park CS
J Microbiol Biotechnol; 2019 Dec; 29(12):1904-1915. PubMed ID: 31635446
[TBL] [Abstract][Full Text] [Related]
2. Complete genome sequence of
Jung DH; Chung WH; Seo DH; Kim YJ; Nam YD; Park CS
3 Biotech; 2020 Feb; 10(2):31. PubMed ID: 31988825
[TBL] [Abstract][Full Text] [Related]
3. The presence of resistant starch-degrading amylases in Bifidobacterium adolescentis of the human gut.
Jung DH; Seo DH; Kim YJ; Chung WH; Nam YD; Park CS
Int J Biol Macromol; 2020 Oct; 161():389-397. PubMed ID: 32479932
[TBL] [Abstract][Full Text] [Related]
4.
Wang B; Kong Q; Cui S; Li X; Gu Z; Zhao J; Zhang H; Chen W; Wang G
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801119
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic analysis of truncation mutants of a type II pullulanase from Bifidobacterium adolescentis P2P3, a resistant starch-degrading gut bacterium.
Kim SY; Kim H; Kim YJ; Jung DH; Seo DH; Jung JH; Park CS
Int J Biol Macromol; 2021 Dec; 193(Pt B):1340-1349. PubMed ID: 34740684
[TBL] [Abstract][Full Text] [Related]
6.
Qian X; Si Q; Lin G; Zhu M; Lu J; Zhang H; Wang G; Chen W
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745208
[TBL] [Abstract][Full Text] [Related]
7. The effect of resistant starch (RS) on the bovine rumen microflora and isolation of RS-degrading bacteria.
Jung DH; Seo DH; Kim GY; Nam YD; Song EJ; Yoon S; Park CS
Appl Microbiol Biotechnol; 2018 Jun; 102(11):4927-4936. PubMed ID: 29654556
[TBL] [Abstract][Full Text] [Related]
8. Screening and selection of Bifidobacterium strains isolated from human feces capable of utilizing resistant starch.
Kim HJ; Shin SI; Lee SJ; Moon TW; Lee CJ
J Sci Food Agric; 2018 Dec; 98(15):5901-5907. PubMed ID: 30009448
[TBL] [Abstract][Full Text] [Related]
9. Ecology- and genome-based identification of the
Argentini C; Lugli GA; Tarracchini C; Fontana F; Mancabelli L; Viappiani A; Anzalone R; Angelini L; Alessandri G; Bianchi MG; Taurino G; Bussolati O; Milani C; van Sinderen D; Turroni F; Ventura M
Appl Environ Microbiol; 2024 Feb; 90(2):e0201423. PubMed ID: 38294252
[TBL] [Abstract][Full Text] [Related]
10. Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA.
Duranti S; Ruiz L; Lugli GA; Tames H; Milani C; Mancabelli L; Mancino W; Longhi G; Carnevali L; Sgoifo A; Margolles A; Ventura M; Ruas-Madiedo P; Turroni F
Sci Rep; 2020 Aug; 10(1):14112. PubMed ID: 32839473
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats.
Li Y; Lv L; Ye J; Fang D; Shi D; Wu W; Wang Q; Wu J; Yang L; Bian X; Jiang X; Jiang H; Yan R; Peng C; Li L
Appl Microbiol Biotechnol; 2019 Jan; 103(1):375-393. PubMed ID: 30345482
[TBL] [Abstract][Full Text] [Related]
12. Prebiotic effects of resistant starch from purple yam (Dioscorea alata L.) on the tolerance and proliferation ability of Bifidobacterium adolescentis in vitro.
Li T; Chen L; Xiao J; An F; Wan C; Song H
Food Funct; 2018 Apr; 9(4):2416-2425. PubMed ID: 29620784
[TBL] [Abstract][Full Text] [Related]
13. Exopolysaccharide-Producing
Yu R; Zuo F; Ma H; Chen S
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987344
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genetic diversity among strains of the human gut commensal Bifidobacterium adolescentis.
Duranti S; Milani C; Lugli GA; Mancabelli L; Turroni F; Ferrario C; Mangifesta M; Viappiani A; Sánchez B; Margolles A; van Sinderen D; Ventura M
Sci Rep; 2016 Apr; 6():23971. PubMed ID: 27035119
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of human gut-associated acetogenic/butyrogenic microbiota based on specific microbial colonization of indigestible starch granules.
Nagara Y; Fujii D; Takada T; Sato-Yamazaki M; Odani T; Oishi K
ISME J; 2022 Jun; 16(6):1502-1511. PubMed ID: 35115640
[TBL] [Abstract][Full Text] [Related]
16. Resistant Starch is Actively Fermented by Infant Faecal Microbiota and Increases Microbial Diversity.
Gopalsamy G; Mortimer E; Greenfield P; Bird AR; Young GP; Christophersen CT
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31208010
[TBL] [Abstract][Full Text] [Related]
17. Orally Administered Bifidobacterium adolescentis Diminishes Serum Glutamate Concentration in Mice.
Royo F; Tames H; Bordanaba-Florit G; Cabrera D; Azparren-Angulo M; Garcia-Vallicrosa C; Margolles A; Ruiz L; Ruas-Madiedo P; Falcon-Perez JM
Microbiol Spectr; 2023 Aug; 11(4):e0506322. PubMed ID: 37347184
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice.
Wang L; Hu L; Xu Q; Yin B; Fang D; Wang G; Zhao J; Zhang H; Chen W
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230723
[TBL] [Abstract][Full Text] [Related]
19.
Long X; Liu D; Gao Q; Ni J; Qian L; Ni Y; Fang Q; Jia W; Li H
Front Endocrinol (Lausanne); 2021; 12():773340. PubMed ID: 35035378
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Bifidobacterium adolescentis ATTCC 15703 supplementation reduces partially allergic airway disease in Balb/c but not in C57BL/6 mice.
Casaro MC; Crisma AR; Vieira AT; Silva GHM; Mendes E; Ribeiro WR; Martins FS; Ferreira CM
Benef Microbes; 2018 Apr; 9(3):465-476. PubMed ID: 29633635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
